SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Attention centers on the approaching FDA decision on Capricors deramiocel for Duchenne muscular dystrophy, with traders weighing the companys amended application and longer-term upper-limb data alongside recent FDA discussion of flexibility in rare-disease reviews. Many are bullish and read commercial hiring as a sign of launch preparation, while skeptics stress that approval is uncertain given the earlier negative review and debate over the evidence; some also cite Inovios separate FDA approval as a positive sentiment signal.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is climbing toward a 52-week high as traders position for anticipated Q3 results, with BRIUMVIs sales growth adding to optimism. Buyout and short-squeeze theories are circulating, but the acquisition talk is unconfirmed, and some traders question whether earnings expectations are already reflected in the run-up.

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the Biopharmaceuticals and Exemplar segments. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Precigen Inc

Inovios FDA approval of a competing treatment for recurrent respiratory papillomatosis has raised concerns about new competition for Precigens PAPZIMEOS. Traders debate the threat: some see a serious challenge, while others argue Precigen retains an advantage from its commercial head start and full approval, and view the selloff as an overreaction.

Okta, Inc. engages in the provision of an identity management platform for enterprises. The firm operates through the following geographical segments: United States and International. Its products include single sign-on, multi-factor authentication, access gateway, API access management, authentication, adaptive MFA and lifecycle management. The company was founded by Todd McKinnon and J. Frederic Kerrest in 2009 and is headquartered in San Francisco, CA.

Okta Inc - Ordinary Shares - Class A

Okta Inc

Traders are discussing Oktas reported addition to the S&P 500 in place of KVUE, with some anticipating index-related buying and others warning of a sell-the-news reaction. Separately, claims of a DHS data exposure involving Oktas login system are adding bearish concern, though those claims are not established in the discussion.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that Medicare reimbursement for DefenCath could decline after early 2027 has fueled concerns about pricing and CorMedixs largest revenue driver. Traders are divided: some see the comments as a serious commercial risk, while others argue DaVitas outlook is preliminary and point to CMSs reimbursement estimate as a counterweight.

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

Mineralys Therapeutics Inc

MLYS is under pressure amid concerns that the slow early commercial ramp for AstraZenecas competing hypertension drug could signal a challenging launch and weaker near-term sales prospects for lorundrostat. Traders disagree on whether that undermines Mineralyss commercial outlook, with some emphasizing the upcoming FDA decision and clinical data while others question its ability to compete independently.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

BNB (BNB) is a cryptocurrency . BNB has a current supply of 131,511,396.41. The last known price of BNB is 698.79071116 USD and is down -6.08 over the last 24 hours. It is currently trading on 3523 active market(s) with $4,017,835,584.29 traded over the last 24 hours. More information can be found at https://bnbchain.org/en.

Binance

A reported major Binance security breach, with withdrawals temporarily suspended and billions in crypto reportedly affected, is driving attention to BNB and broader crypto-market concerns. Traders are debating whether the incident threatens trust in Binance and warrants further selling, while others view the selloff as an overreaction; claims of an inside job remain speculation.

Permian Resources Corp. is an oil and natural gas company, which focuses on returns to stakeholders through the responsible acquisition, optimization and development of crude oil and associated liquids-rich natural gas reserves. The company was founded on December 18, 2025 and is headquartered in Midland, TX.

Permian Resources Holdings Inc. - Ordinary Shares - Class A

Permian Resources Corp - Ordinary Shares - Class A

Permian Resources is being discussed amid volatile crude prices and shifting Middle East supply risks, especially tensions and shipping disruptions around the Strait of Hormuz. Traders debate why PR often fails to track oils moves, while some point to the companys production growth, guidance and dividends as support for a longer-term bullish view.

Centrus Energy Corp. engages in the supply of nuclear fuel and services for the nuclear power industry. It operates through the Low-Enriched Uranium (LEU) and Technical Solutions segments. The LEU segment includes various components of nuclear fuel to utilities from its global network of suppliers. The Technical Solutions segment offers advanced engineering, design, and manufacturing services to government and private sector customers, and is deploying advanced nuclear fuel production capabilities to power existing, and next-generation reactors around the world. The company was founded in October 1992 and is headquartered in Bethesda, MD.

Centrus Energy Corp - Ordinary Shares - Class A

Centrus Energy Corp 

Centruss steep selloff is the dominant topic, with traders citing share dilution and the cost and execution risks of expanding enrichment capacity, alongside weakness across nuclear stocks. Bulls point to its strategic U.S. HALEU supply role and government contracts as long-term support, while others question the valuation and whether the decline has further to run.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Are Smaller Home Projects Sustaining Home Depot's Sales Growth?

HD's sales growth is supported by steady demand for smaller home projects and digital gains, even as larger renovations face persistent pressure.

SGI vs. HD: Which Stock Is the Better Value Option?

Why Home Depot (HD) is a Top Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.

Home Depot vs. Lowe's: Which Retail Giant Is Worth Betting On?

Home Depot's Pro investments, sales growth and digital gains contrast with Lowe's contractor expansion, margin improvement and lower valuation.

The Home Depot Foundation Pledges $1 Billion to Veteran Causes by 2032

The Home Depot Foundation Pledges $1 Billion to Veteran Causes by 2032 The Home Depot Foundation Pledges $1 Billion to Veteran Causes by 2032PR NewswireATLANTA, Oct. 22, 2026 Expanded commitment will develop and grow innovative housing solutionsto help end veteran homelessnessKey Facts: $1 Billion...

Why Home Depot (HD) Outpaced the Stock Market Today

Home Depot (HD) concluded the recent trading session at $315.06, signifying a +1.67% move from its prior day's close.

Here is What to Know Beyond Why The Home Depot, Inc. (HD) is a Trending Stock

Zacks.com users have recently been watching Home Depot (HD) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Why Home Depot (HD) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.

The Zacks Analyst Blog Highlights NVIDIA, Philip Morris International, Home Depot and CPI Aerostructures

NVIDIA, Philip Morris and Home Depot face key growth drivers and risks as Q3 earnings season unfolds, while CPI Aerostructures benefits from rising defense orders.

The Home Depot, Inc. engages in the sale of building materials and home improvement products. Its products include building materials, home improvement products, lawn and garden products and décor products. The firm operates through the following geographical segments: U.S., Canada and Mexico. It offers home improvement installation services, and tool and rental equipment. The company was founded by Bernard Marcus, Arthur M. Blank, Kenneth Gerald Langone and Pat Farrah on June 29, 1978 and is headquartered at Atlanta, GA.

Home Depot, Inc.

Home Depot Or Lowe’s? Morningstar Says One Home-Improvement Stock Looks Cheaper 

Equity

Bearish Sentiment

<ul class="summary-bullets"><li>Morningstar’s Dave Sekera said Lowe’s offers a more attractive valuation than Home Depot following Q2 results.&nbsp;</li><li>Home Depot’s Q2 operating margin fell to 14.7%, with Sekera warning that higher mortgage costs and housing pressures could continue weighing on home-improvement spending.&nbsp;&nbsp;&nbsp;</li><li>Meanwhile, the analyst sees 3% long-term comparable-sales growth and a 13.7% margin.&nbsp;</li></ul>Home Depot (HD) and Lowe’s Companies (LOW) are both dealing with a weak housing market, but Morningstar sees a clearer opportunity in one of them. Morningstar Chief U.S. Market Strategist Dave Sekera prefers Lowe’s, saying it looks more attractive at its current price. Home Depot trades above Morningstar’s fair value, while Lowe’s is about 15% below it, leaving more room to rise.&nbsp;<h2 class="st-heading-2">Lowe’s Attractive Over Home Depot As Valuation Gap Widens</h2>Home-improvement giants Home Depot and Lowe’s are facing a difficult housing backdrop, and following the companies’ fiscal second-quarter (Q2) 2026 results, Sekera said Lowe’s offers the more compelling combination of valuation and longer-term expectations, while Home Depot’s stock remains above Morningstar’s estimate of intrinsic value.&nbsp;Home Depot’s Q2 revenue rose 5.7%, helped in part by acquisitions, while sales at existing stores increased 1.7%. Its operating margin fell to 14.7% as higher costs reduced the benefit from tariff refunds. Morningstar kept its $325 fair value estimate unchanged. Sekera said the key concern is what happens after 2026, especially whether higher costs will keep hurting profits or if Home Depot can maintain its profit margins.&nbsp;The weak housing market remains a major concern. Sekera pointed to Morningstar research showing that the average monthly mortgage payment for a typical U.S. home has risen by about $1,000 over the past five years. About half of the increase comes from higher borrowing costs, making homeowners less likely to spend on big renovation projects.&nbsp;<a href="https://stocktwits.com/symbol/HD">Home Depot stock</a> inched 0.3% lower in Wednesday’s premarket, while&nbsp;<a href="https://stocktwits.com/symbol/LOW">Lowe’s stock</a> rose 0.4%.&nbsp;<h2 class="st-heading-2">Lowe’s Delivers Revenue But Lacks Balance</h2>Lowe’s Q2 revenue increased 8%, racing past Home Depot’s growth. However, comparable sales gained just 0.2%. High transportation and fuel costs shricked Lowe’s operating margin by 62 basis points, while the company lowered its profit outlook to the lower end of its previous range.Even so, Morningstar retained its $255 fair value estimate. Sekera expects Lowe’s to eventually produce about 3% annual comparable-sales growth and a 13.7% operating margin, above what the market currently appears to anticipate.Sekera said both stocks have weakened over the past year, but he views the declines differently. Home Depot still trades above Morningstar’s long-term valuation, while Lowe’s trades at roughly a 15% discount to that estimate. According to Koyfin data, HD trades at a price-to-earnings (P/E) multiple of 21.9, while LOW is trading at 17.1X.<figure class="image"><img src="https://news.stocktwits-cdn.com/koyfin_20260826_043424341_598705cc2a.png" alt="koyfin_20260826_043424341.png" width="2400" height="1240"></figure>While HD stock declined nearly 2%, LOW stock has dropped 11% year to date.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/black-berry-is-done-with-smartphones-and-cars-now-it-wants-to-own-the-software-inside-your-ai-robot/cZYNFqTRJYP">BlackBerry Is Done With Smartphones And Cars — Now It Wants To Own The Software Inside Your AI Robot</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Customers shop at a Lowe's home improvement store in Chicago.

Dave Sekera cited Lowe’s 15% discount to fair value and stronger long-term prospects.

Home Depot Or Lowe’s? Morningstar Says One Home-Improvement Stock Looks Cheaper

Dave Sekera cited Lowe’s 15% discount to fair value and stronger long-term prospects. 


Lowe's Companies, Inc.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Futures

Fundamentals

Info

HD Futures

HD Single Stock Futures